scholarly journals Interventional Treatment Options for Trigeminal Neuralgia

2020 ◽  
Author(s):  
Yashar Eshraghi ◽  
Sarah J. Vitug ◽  
Maged Guirguis
Keyword(s):  
Trigeminal Neuralgia ◽  
Treatment Options ◽  
Interventional Treatment

scholarly journals Trigeminal Neuralgia, Glossopharyngeal Neuralgia, and Myofascial Pain Dysfunction Syndrome: An Update

2017 ◽  
Vol 2017 ◽  
pp. 1-18 ◽  
Author(s):  
Mohammad Khan ◽  
Shamima Easmin Nishi ◽  
Siti Nazihahasma Hassan ◽  
Md. Asiful Islam ◽  
Siew Hua Gan
Keyword(s):  
Trigeminal Neuralgia ◽  
Myofascial Pain ◽  
Trigger Point ◽  
Treatment Options ◽  
Neck Region ◽  
Diagnostic Procedures ◽  
Glossopharyngeal Neuralgia ◽  
Myofascial Pain Dysfunction ◽  
Central Nervous Systems ◽  
Masticatory Process

Neuropathic pain is a common phenomenon that affects millions of people worldwide. Maxillofacial structures consist of various tissues that receive frequent stimulation during food digestion. The unique functions (masticatory process and facial expression) of the maxillofacial structure require the exquisite organization of both the peripheral and central nervous systems. Neuralgia is painful paroxysmal disorder of the head-neck region characterized by some commonly shared features such as the unilateral pain, transience and recurrence of attacks, and superficial and shock-like pain at a trigger point. These types of pain can be experienced after nerve injury or as a part of diseases that affect peripheral and central nerve function, or they can be psychological. Since the trigeminal and glossopharyngeal nerves innervate the oral structure, trigeminal and glossopharyngeal neuralgia are the most common syndromes following myofascial pain dysfunction syndrome. Nevertheless, misdiagnoses are common. The aim of this review is to discuss the currently available diagnostic procedures and treatment options for trigeminal neuralgia, glossopharyngeal neuralgia, and myofascial pain dysfunction syndrome.

Diagnostic radiology findings and spectrum of therapeutic interventions in gynaecological and urogenital vascular anomalies

2021 ◽  
pp. 20210246
Author(s):  
Nadja Grill ◽  
Felix Struebing ◽  
Lena Krebs ◽  
Maliha Sadick
Keyword(s):  
Treatment Options ◽  
Vascular Anomaly ◽  
Vascular Anomalies ◽  
Urogenital Tract ◽  
Diagnostic Radiology ◽  
Therapeutic Interventions ◽  
Interdisciplinary Management ◽  
Interventional Treatment ◽  
Invasive Treatment ◽  
Pictorial Review

Vascular anomalies represent a rare congenital disease with manifestation at diverse anatomical sights and presenting with heterogenous symptoms. Undetected, they can progress and create acute and chronic complications with functional impairment. The manifestation in the female and male pelvis and the urogenital tract represents a multidisciplinary challenge for physicians. Especially outpatient management in gynaecology and urology is affected. Diagnostic Radiology holds an important supportive role in early diagnosis of the underlying urogenital vascular anomaly and referral to interventional radiology, either for minimal invasive treatment, or to surgery for further assessment. This pictorial review creates awareness for the spectrum of vascular anomalies of the gynaecological and urogenital tract, their characteristic imaging findings and dedicated interventional treatment options. The individual description of vascular anomalies, based on an appropriate nomenclature and classification standard, is a guide for radiologists to distinguish the underlying vascular anomaly from other vascular disorders and to accelerate diagnosis as well as therapeutic proceedings. In consequence, interdisciplinary management of patients with vascular anomalies of the female and male pelvis will benefit.

scholarly journals Gamma Knife Radiosurgery for Primary and Secondary Trigeminal Neuralgia

Neurosurgery ◽  
2019 ◽  
Vol 66 (Supplement_1) ◽  
Author(s):  
Sunil K Gupta
Keyword(s):  
Pain Relief ◽  
Trigeminal Neuralgia ◽  
Microvascular Decompression ◽  
Treatment Modality ◽  
Pain Control ◽  
Treatment Options ◽  
Gamma Knife Radiosurgery ◽  
Clinical Criteria ◽  
Grade Iii

Abstract INTRODUCTION Trigeminal neuralgia has always been a disease of conflict from pathological and management perspectives. Despite advances in the radiological imaging, evidence from autopsy studies, and intraoperative findings, concrete answers are not in sight. GKRS has been a strong contender among available treatment options for the management of trigeminal neuralgia. METHODS All patients were evaluated on clinical criteria, BNI scale for intensity of pain, and facial hypoesthesia (if any) in a protocol-based manner. Only patients with BNI III to V were offered GKRS as a treatment modality. The Marseille point was targeted with a 70 to 90 Gy dose at 50% isodose. Patients were informed about all available treatment options with long-term prognosis and pain control rates. Patients in need of an immediate pain relief, in failed GKRS, and in a severe pain jeopardizing routine life and eating habits were not offered GKRS and were managed with microvascular decompression. RESULTS A total of 108 (65 males, 43 females) patients received GKRS with the Perfexion model since 2009. Eighty-two percent of the patients received GKRS for primary trigeminal neuralgia, while the rest received GKRS for secondary trigeminal neuralgia due to skull base lesions (meningioma, schwannoma, cerebellar AVM, etc). A total of 78% of the patients had preoperative BNI scale IV, while 19% and 3% of the patients had grade III and V scale pain, respectively. Ninety-four percent patients gained BNI scale III intensity pain within 3 mo of GKRS. The 3-yr pain control rate (BNI I-II) could be attained in 81% of the patients. Twelve percent of the patients remained in BNI grade III. Two patients needed redo GKRS for their pain recurrence. CONCLUSION It remains uncontested that MVD provides the best long-term pain-free control in patients of trigeminal neuralgia; however, GKRS remains a valuable feasible option for a selected group of patients. GKRS should be offered as an alternative treatment modality in patients not in urgent need of pain relief. In failed GKRS, authors did not encounter any difficulty in microvascular decompression.

scholarly journals Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Giulia Di Stefano ◽  
Stine Maarbjerg ◽  
Andrea Truini
Keyword(s):  
Multiple Sclerosis ◽  
Trigeminal Neuralgia ◽  
Clinical Picture ◽  
Treatment Options

Interventional Treatment Options for Advanced Emphysema: Imaging Manifestations

2009 ◽  
Vol 24 (3) ◽  
pp. 195-205 ◽  
Author(s):  
Victor Kim ◽  
Robert M. Steiner
Keyword(s):  
Treatment Options ◽  
Interventional Treatment

scholarly journals Image-guided elbow interventions: a literature review of interventional treatment options

2016 ◽  
Vol 89 (1057) ◽  
pp. 20150368 ◽  
Author(s):  
Alan Sorani ◽  
Robert Campbell
Keyword(s):  
Literature Review ◽  
Treatment Options ◽  
Interventional Treatment ◽  
Image Guided

Endovascular management of acute ischemic stroke

2009 ◽  
Vol 26 (3) ◽  
pp. E2 ◽  
Author(s):  
Chirag D. Gandhi ◽  
Lana D. Christiano ◽  
Charles J. Prestigiacomo
Keyword(s):  
Acute Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Treatment Options ◽  
Antiplatelet Agents ◽  
Interventional Treatment ◽  
Long Term Outcomes ◽  
Treatment Protocols ◽  
Tissue Plasminogen

The management of stroke has progressed significantly over the past 2 decades due to successful treatment protocols including intravenous and intraarterial options. The intravenous administration of tissue plasminogen activator within an established treatment window has been proven in large, well-designed studies. The evolution of endovascular strategies for acute stroke has been prompted by the limits of the intravenous treatment, as well as by the desire to demonstrate improved recanalization rates and improved long-term outcomes. The interventional treatment options available today are the intraarterial administration of tissue plasminogen activator and newer antiplatelet agents, mechanical thrombectomy with the MERCI device and the Penumbra system, and intracranial angioplasty and stent placement. In this review the authors outline the major studies that have defined the current field of acute stroke management and discuss the basic treatment paradigms that are commonly used today.

scholarly journals Treatment options for trigeminal neuralgia

BMJ ◽  
2003 ◽  
Vol 327 (7428) ◽  
pp. 1360-1361 ◽  
Author(s):  
A. F A Merrison
Keyword(s):  
Trigeminal Neuralgia ◽  
Treatment Options

scholarly journals Trigeminal Neuralgia

2021 ◽  
pp. 531-546
Author(s):  
Kandasamy Ganesan ◽  
Asha Thomson
Keyword(s):  
Trigeminal Neuralgia ◽  
Trigeminal Nerve ◽  
Treatment Options ◽  
Gamma Knife Radiosurgery ◽  
Clinical History ◽  
Sensory Innervation ◽  
Root Entry Zone ◽  
Course Of Action ◽  
Set Up ◽  
Self Help Groups

AbstractNeuralgia can be defined as paroxysmal, intense intermittent pain that is usually confined to specific nerve branches to the head and neck. The trigeminal nerve is responsible for sensory innervation of the scalp, face and mouth, and damage or disease to this nerve may result in sensory loss, pain or both. >85% of cases of Trigeminal Neuralgia are of the classic type known as Classical Trigeminal Neuralgia (CTN), while the remaining cases can be separated to secondary Trigeminal Neuralgia (STN). STN is thought to be initiated by multiple sclerosis or a space-occupying lesion affecting the trigeminal nerve, whereas the leading cause of CTN is known to be compression of the trigeminal nerve in the region of the dorsal root entry zone by a blood vessel. There is no guaranteed cure for the condition of Trigeminal Neuralgia, but there are several treatment options that can give relief. In this chapter, we review the common neuralgias occurring within the oral and maxillofacial region with special emphasis on Trigeminal Neuralgia. We will discuss the historical evolution of treatment including the medical and surgical modalities with the use of current literature and newer developments. It has been highlighted that the first line of treatment for trigeminal neuralgia is still pharmacological treatment, with Carbamazepine and Oxcarbazepine being the first choice. Possible surgical methods of treatment are discussed within this chapter including modalities such as Microvascular Decompression, Gamma Knife Radiosurgery and Peripheral Neurectomy. As an OMF surgeon, it is important to obtain a good clinical history to rule out other pathology including dental focus. Many clinicians involved ranging from primary care dentists and doctors to secondary care (neurologists, Oral Medicine, OMFS, etc.) to deliver the appropriate first course of action, which is the medical management. The management of TN patients should be carried out in a multidisciplinary setting to allow the patients to choose the best-suited option for them. It is also important to set up self-help groups to enable them to share knowledge and information for themselves and their family members for the best possible outcomes.

Sign in / Sign up

Export Citation Format

Share Document